A carregar...
Genetic polymorphisms of STAT3 correlated with prognosis in diffuse large B-cell lymphoma patients treated with rituximab
BACKGROUND: Rituximab in the combination of CHOP chemotherapy has been widely used as the standard treatment for several kinds of B-cell non-Hodgkin lymphoma (B-NHL). Inactivation of phosphorylation of STAT3 plays an essential role in rituximab-induced anti-proliferative activity in B-cell lymphoma....
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4007516/ https://ncbi.nlm.nih.gov/pubmed/24624997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-14-25 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|